<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5283595 Figure_1-A-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Abnormal distribution of Cux1-positive neurons in CAMDI-KO mice. Expression of Cux1 in the somatosensory cortex was compared between P2 wild-type (WT) and CAMDI-KO (KO) mice. Scale bar, 100 &#956;m. (B) Quantification of the number of Cux1-positive neurons. Note the abnormal distribution of neurons in deep cortical layers of CAMDI-KO mice. n = 3 mice/genotype (WT = 788 cells, KO = 2,139 cells). *, p&lt;0.05, **, p&lt;0.01, ***, p&lt;0.001, Two-way ANOVA followed by Scheffe's post-hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_1-C-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Delay in neuronal migration by CAMDI deletion. Coronal sections through the somatosensory cortex of P21 WT and CAMDI-KO mice were analyzed following in utero electroporation of EGFP plasmid at E14.5. Scale bar, 100 &#956;m. (D) Quantification of the number of EGFP-positive neurons. Note the abnormal distribution of neurons in lower cortical layers of CAMDI-KO mice. n = 3 for WT mice (546 cells), n = 4 for KO mice (680 cells). *, p&lt;0.05, ***, p&lt;0.001. Two-way ANOVA followed by Scheffe's post-hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_1-E-F</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Aberrant axonal projection and terminal arbors by CAMDI deletion. Coronal sections through the somatosensory cortex of P21 WT and CAMDI-KO mice were analyzed following in utero electroporation of EGFP plasmid at E14.5. Representative pictures show an aberrant axonal projection of corticostriatal neurons in CAMDI-KO mice. Sections were stained with Hoechst 33258 and anti-EGFP antibody. Scale bar, 1 mm. (F) Quantification of the striatal intensity. n = 3 mice/genotype. ***, p&lt;0.001, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-A-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Representative traces from adult control (WT) and CAMDI-KO (KO) in open field test. Locomotor activity (A) and distance traveled (B) for 15 min. n = 8 for WT mice, n = 7 for KO mice. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test (F(1, 13) = 5.53). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-C</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Repetitive jumping behavior in open field test. n = 8 for WT mice, n = 7 for KO mice. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test (F(1, 13) = 5.09). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Three-chamber social interaction test. The time spent sniffing with stranger mouse. n = 19 for WT mice, n = 15 for KO mice. *, p&lt;0.05, ***, p&lt;0.001,Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 63)=5.79, main effect of chamber F(1, 63)=90.47, interaction F(1, 63)=5.29). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-E</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Resident-intruder test (social sniffing). n = 7 for WT mice, n = 8 for KO mice. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test (F(1, 13) = 5.15). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-F</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Resident-intruder test (digging). n = 7 for WT mice, n = 8 for KO mice. **, p&lt;0.01, One-way ANOVA with Bonferroni's post hoc test (F(1, 13) = 10.97). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-G</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Marble burying test. n = 9 for WT mice, n = 25 for KO mice. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test (F(1, 32) = 5.39). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-H</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Forced swimming test. n = 10 for WT mice, n = 13 for KO mice. **, p&lt;0.01, ***, p&lt;0.001 Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 42)=84.30, main effect of session F(1, 42)=33.88, interaction F(1, 42)=4.92). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-I-J</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(I, J) Light-dark test. Time in light chamber (I) and Latency to light chamber (J). n = 8 for WT mice, n = 7 for KO mice. *, p&lt;0.05, **, p&lt;0.01, One-way ANOVA with Bonferroni's post hoc test, ((I) F(1, 13) = 8.75, (J) F(1, 13)=9.73). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_2-K</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 2-K</infon>
    <infon key="sourcedata_figure_dir">Figure_2-K</infon>
    <passage>
      <offset>0</offset>
      <text>(K) Hot plate test.. n = 8 for WT mice, n = 12 for KO mice. **, p&lt;0.01, One-way ANOVA with Bonferroni's post hoc test (F(1, 18) = 17.51). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_3-A</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Co-expressed FLAG-CAMDI and HDAC6-HA interacted with each other in SH-SY5Y cells. n=3 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_3-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Endogenous interaction of CAMDI with HDAC6 in the mouse brain. Co-IP assay was performed with the indicated antibodies using E16 mouse brain. n=3 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_3-C-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D) N-terminal region of CAMDI recognizes the second HDAC domain of HDAC6. SH-SY5Y cells were co-transfected with HDAC6-HA and each FLAG-CAMDI fragment (C) (fragment 1, 1-250; 2, 251-500; 3, 501-750; 4, 751-1000; 5, 1001-1451 amino acids) or co-transfected with FLAG-CAMDI and each HDAC6-HA fragment (D) (fragment 1 (DD1), 1-440; 2 (DD2), 441-840; 3, 841-1215 amino acids). Co-IP assay was performed with the indicated antibodies. n=3 independent experiments. **, p&lt;0.01, ***, p&lt;0.001, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_4-A</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) CAMDI and CAMDI Fragment 1 overexpression enhanced &#945;-tubulin acetylation. HeLa cells overexpressing FLAG-CAMDI and FLAG-CAMDI frag.1 were immunostained with anti-FLAG or anti-Ac-tubulin antibodies. Ratio line-scans along the line (from x- to y-axis) from images. Scale bar, 10 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_4-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B-C) CAMDI blocked HDAC6-mediated &#945;-tubulin deacetylation. (B) Centrosomal fraction was isolated from cell lysates of SH-SY5Y cells expressing each construct, and Ac-tubulin level was assessed by immunoblot analysis. n = 3 independent experiments. **, p&lt;0.01, ***, p&lt;0.001, Two-way ANOVA followed by Scheffe's post-hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_4-C</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B-C) CAMDI blocked HDAC6-mediated &#945;-tubulin deacetylation. (C) CAMDI N-terminal domain alone increased Ac-tubulin level. n=3 independent experiments. **, p&lt;0.01, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_4-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Deletion of CAMDI N-terminal domain (1-250 amino acids) failed to inhibit HDAC6. n = 3 independent experiments. N.S., not significant. Two-way ANOVA followed by Scheffe's post-hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_5-A-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Effect of HDAC6 over-expression or CAMDI co-expression on the level of acetylated &#945;-tubulin in the centrosome. HeLa cells co-transfected with Centrin2-EGFP with/without HDAC6-HA and FLAG-CAMDI were immunostained with anti-EGFP (green) and anti-acetylated &#945;-tubulin antibodies (red). Scale bar, 1 &#956;m. (B) Quantification of intensity of acetylated &#945;-tubulin at centrosome. n = 25, 30, 30 cells. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_5-C-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Effects of HDAC6 overexpression or CAMDI co-expression on the centrosomal localization of &#947;-tubulin. HeLa cells co-transfected with Centrin2-EGFP with/without HDAC6-HA and FLAG-CAMDI were immunostained with anti-EGFP (green) and anti-&#947;-tubulin antibodies (red). DNA was stained with Hoechst 33258. Scale bar, 1 &#956;m. (D) Quantification of intensity of &#947;-tubulin at centrosome. n = 39, 16, 17 cells. *, p&lt;0.05, **, p&lt;0.01, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_5-E</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) CAMDI stabilizes centrosomal &#947;-tubulin through HDAC6 inhibition. Centrosomal fraction was isolated from cell lysates of SH-SY5Y cells expressing each construct, and &#947;-tubulin level was assessed by immunoblot analysis. n = 3 independent experiments. **, p&lt;0.01, One-way ANOVA followed with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_5-F</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Effects of CAMDI knockdown on the centrosomal localization of &#947;-tubulin in vivo. Coronal sections through the somatosensory cortex of E17.5 were analyzed following in utero electroporation of EGFP and CAMDI-sh plasmid at E14.5. The sections were immunostained with anti-EGFP (green) and anti-&#947;-tubulin antibodies (red). Representative images of EGFP at Cortical Plateneuron expressing CAMDI-sh stained for endogenous &#947;-tubulin and with Hoechst (blue). Z-stack number 6 indicates centrosome of EGFP-positive CAMDI-sh-expressing neuron. Z-stack number 19 indicates centrosome of a nearby non-electroporated neuron. Quantification of &#947;-tubulin intensity. EGFP (-) = 12 cells, EGFP (+) (CAMDI-sh) = 12 cells. *, p&lt;0.05, One-way ANOVA with Bonferroni's post hoc test. Data are presented as mean &#177; SEM. Scale bar, 5 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_5-G</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Reduced &#947;-tubulin in the centrosome fraction of CAMDI-KO brain. The centrosomal fraction was isolated from brain lysates of WT and CAMDI-KO mice and &#947;-tubulin level was assessed by immunoblot analysis. n = 3 independent experiments. **, p&lt;0.01, One-way ANOVA followed with Bonferroni's post hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_6-A-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Rescue of a delayed cortical migration in CAMDI-KO mice by Tubastatin A. Immunohistochemical analysis of Cux1 expression in the somatosensory cortex at P2 after intraperitoneal injections of Tubastatin A into pregnant CAMDI-KO mice from E12.5-17.5. Scale bar, 100 &#956;m. (B) Quantification of the number of Cux1-positive neurons. Note the abnormal distribution of neurons in deep cortical layers of CAMDI-KO mice. n = 3 mice/genotype (WT (vehicle) = 3,628 cells, KO (vehicle) = 2,816 cells, WT (Tubastatin A) = 1,847 cells, KO (Tubastatin A) = 2,364 cells). *, p&lt;0.05, **, p&lt;0.01, Two-way ANOVA followed by Tukey HSD test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_6-C-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Enhanced &#945;-tubulin acetylation at P0 by Tubastatin A. Ac-tubulin level was assessed by immunoblot analysis. (D) Quantification of the &#945;-tubulin acetylation. n=3 independent experiments. *, p&lt;0.05, Two-way ANOVA followed by Scheffe's post-hoc test. Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_7-A-B</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative traces from control (WT) and CAMDI-KO (KO) mice in the open field test at P21. Sample traces of locomotor activity were shown. (B) Distance traveled for 10 min. n = 13 for WT (vehicle) mice, n = 13 for KO (vehicle) mice, n = 5 for WT (Tubastatin A) mice, n = 16 for KO (Tubastatin A) mice. **, p&lt;0.01, ***, p&lt;0.001. Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 43)=6.25, main effect of drug F(1, 43)=2.14, interaction F(1, 43)=12.68). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_7-C</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Repetitive jumping behavior. n = 13 for WT (vehicle) mice, n = 27 for KO (vehicle) mice, n = 5 for WT (Tubastatin A) mice, n = 18 for KO (Tubastatin A) mice. **, p&lt;0.01, ***, p&lt;0.001. Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 59)=5.04, main effect of drug F(1, 59)=10.13, interaction F(1, 59)=4.98). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_7-D</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Grooming time in small open field test. n = 13 for WT (vehicle) mice, n = 13 for KO (vehicle) mice, n = 5 for WT (Tubastatin A) mice, n = 16 for KO (Tubastatin A) mice. **, p&lt;0.01, ***, p&lt;0.001. Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 43)=11.18, main effect of drug F(1, 43)=7.23, interaction F(1, 43)=9.34). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_7-E</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Distance traveled for 15 min. n = 10 for adult WT (Vehicle) mice, n = 5 for KO (Vehicle) mice, n = 6 for WT (Tubastatin A) mice, n = 11 for KO (Tubastatin A) mice. **, p&lt;0.01, Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 28)=1.73, main effect of drug F(1, 28)=3.96, interaction F(1, 28)=11.80). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283595 Figure_7-F</id>
    <infon key="sourcedata_document">2309</infon>
    <infon key="doi">10.15252/embr.201642416</infon>
    <infon key="pmc_id">5283595</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Light-dark test. Time in latency to the light chamber (latency). n = 10 for adult WT (Vehicle) mice, n = 5 for KO (Vehicle) mice, n = 6 for WT (Tubastatin A) mice, n = 11 for KO (Tubastatin A) mice. *, p&lt;0.05, Two-way ANOVA followed by Scheffe's post-hoc test (main effect of genotype F(1, 28)=2.34, main effect of drug F(1, 28)=3.82, interaction F(1, 28)=10.64). Data are presented as mean &#177; SEM.</text>
    </passage>
  </document>
</collection>
